Moreover, in earlier attempts to alleviate molecular incompatibilities in the coagulation cascade, transgenic expression of thrombomodulin (TBM), endothelial protein C receptor (EPCR), and CD47 minimized the thrombotic microangiopathy (TMA) that led to early graft failure. This evidence concerns the gene THBD and thrombotic microangiopathy.